Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/TE1 stock hub

FRA/TE1 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/TE1is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.4B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/TE1

In the news

Latest news · FRA/TE1

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E23.8

P25 n/aP50 n/aP75 n/a

Trailing P/E67.7

P25 n/aP50 n/aP75 n/a

ROE5.3

P25 n/aP50 n/aP75 n/a

ROIC10.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/TE1 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

229

Groups with data

Currency

USD

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	3,100
Employees Change	0%
Employees Change Percent	0
Enterprise value	EUR 6.5B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 6.4B
Price	EUR 40.36
Price currency	EUR
Rev Per Employee	338,753.67x
Sic	2836
Symbol	fra/TE1
Website	https://www.bio-techne.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.48%
EV Earnings	68.42x
EV/EBIT	24.63x
EV/EBITDA	19.61x
EV/FCF	27.79x
EV/Sales	6.32x
FCF yield	3.63%
Forward P/E	23.81x
P/B ratio	3.56x
P/E ratio	67.74x
P/S ratio	6.13x
PE Ratio10 Y	64.44x
PE Ratio3 Y	75.05x
PE Ratio5 Y	74.3x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	25.58%
EBITDA Margin	30.23%
FCF margin	22.27%
Gross margin	66.4%
Gross Profit	EUR 697.3M
Gross Profit Growth	-0.18%
Gross Profit Growth Q	-2.63%
Gross Profit Growth3 Y	1.62%
Gross Profit Growth5 Y	7.1%
Net Income	EUR 95M
Net Income Growth	-16.79%
Net Income Growth Q	125.99%
Net Income Growth3 Y	-26.09%
Net Income Growth5 Y	-9.87%
Pretax Margin	12.15%
Profit Margin	9.05%
Profit Per Employee	EUR 30,635
ROA	7.45
Roa5y	6.84
ROCE	12.92
ROE	5.34
Roe5y	10.62
ROIC	10.72
Roic5y	11.68

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	7.06%
Cagr15y	8.74%
Cagr1y	-5.16%
Cagr3y	-18.44%
Cagr5y	-13.26%
Div CAGR10	-0.4%
Div CAGR3	-3.58%
Div CAGR5	0.07%
EPS Growth	-15.36
EPS Growth Q	128.6
EPS Growth3 Y	-25.49
EPS Growth5 Y	-9.56
FCF Growth	22.13%
FCF Growth Q	150.27%
FCF Growth3 Y	5.02%
FCF Growth5 Y	3.72%
OCF Growth	11.33%
OCF Growth Q	110.75%
OCF Growth10 Y	7.38%
OCF Growth3 Y	2.51%
OCF Growth5 Y	1.41%
Revenue Growth	0.17x
Revenue Growth Q	-1.51x
Revenue Growth3 Y	2.52x
Revenue Growth5 Y	7.39x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.47
Assets	EUR 2.2B
Cash	EUR 185.7M
Current Assets	EUR 583.4M
Current Liabilities	EUR 130M
Debt	EUR 251.8M
Debt EBITDA	EUR 0.75
Debt Equity	EUR 0.14
Debt FCF	EUR 1.08
Equity	EUR 1.8B
Interest Coverage	31.98
Liabilities	EUR 403.6M
Long Term Assets	EUR 1.6B
Long Term Liabilities	EUR 273.6M
Net Cash	EUR -66.1M
Net Cash By Market Cap	EUR -1.03
Net Debt EBITDA	EUR 0.21
Net Debt Equity	EUR 0.04
Net Debt FCF	EUR 0.28
Tangible Book Value	EUR 683.8M
Tangible Book Value Per Share	EUR 4.37

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.49
Inventory Turnover	2.07
Net Working Capital	EUR 290.4M
Quick ratio	2.8
Working Capital	EUR 463.8M
Working Capital Turnover	EUR 2.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.27%
Dividend Growth	-7.19%
Dividend Growth Years	0%
Dividend per share	EUR 0.28
Dividend Years	19
Dividend Yield	0.68%
Ex Div Date	2026-02-13
Last Dividend	EUR 0.07
Payout Frequency	Quarterly
Payout Ratio	45.47%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	97.87%
1Y total return	-5.15%
200-day SMA	49.47
3Y total return	-45.75%
50-day SMA	46.32
50-day SMA vs 200-day SMA	50under200
5Y total return	-50.91%
All Time High	115
All Time High Change	-64.9%
All Time High Date	2021-09-15
All Time Low	10.5
All Time Low Change	284.38%
All Time Low Date	2010-11-05
ATR	1.84
Ch YTD	-18.63
High	42.82
High52	60.5
High52 Date	2026-01-22
High52ch	-33.29%
Low	40.36
Low52	39.66
Low52 Date	2026-05-07
Low52ch	1.77%
Ma50ch	-12.87%
Price vs 200-day SMA	-18.42%
RSI	35.16
RSI Monthly	37.54
RSI Weekly	38.52
Sharpe ratio	-0.05x
Sortino ratio	0.05
Total Return	2.96%
Tr YTD	-18.53
Tr15y	251.49%
Tr1m	-12.11%
Tr1w	-12.62%
Tr3m	-28.48%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 268.6M
Operating Income Growth	40.06
Operating Income Growth Q	71.92
Operating Income Growth3 Y	6.61
Operating Income Growth5 Y	8.55
Operating margin	25.58

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	154,661,627%
Net Borrowing	-110,235,060
Shares Insiders	1.14%
Shares Institutions	116.79%
Shares Qo Q	0.26%
Shares Yo Y	-2.27%
Short Ratio	5.66

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 198.5M
Average Volume	0.65x
Bv Per Share	11.56
CAPEX	EUR -21.9M
Ch10y	85.79
Ch15y	205.8
Ch1m	-12.11
Ch1w	-12.62
Ch1y	-5.7
Ch3m	-28.57
Ch3y	-46.54
Ch5y	-51.95
Ch6m	-17.97
Change	1.77%
Change From Open	-5.74
Close	39.66
Days Gap	7.97
Depreciation Amortization	47,764,851.5
Earnings Date	2026-08-05
EBIT	EUR 268.6M
EBITDA	EUR 317.5M
EPS	EUR 0.6
F Score	7
FCF	EUR 233.8M
FCF EV Yield	3.6x
Financing CF	-196,320,293
Fiscal Year End	June
Founded	1,976
Graham Number	12.33376
Graham Upside	-69.44
Income Tax	EUR 32.6M
Investing CF	-9,303,527
Is Primary Listing	0
Last Earnings Date	2026-02-04
Last Report Date	2026-03-31
Last Split Date	2022-11-30
Last Split Type	Forward
Lynch Fair Value	EUR 2.98
Lynch Upside	-92.62
Ma150	50.72
Ma150ch	-20.42%
Ma20	46.95
Ma20ch	-14.03%
Net CF	59,972,928
Next Earnings Date	2026-08-05
Open	42.82
P FCF Ratio	27.51
P OCF Ratio	25.15
Payment Date	2026-02-27
Position In Range	0
Ppne	255,496,038.4
Price Date	2026-05-08
Price EBITDA	EUR 20.26
Ptbv Ratio	9.41
Relative Volume	20x
Revenue	1,050,136,380x
SBC By Revenue	3.36x
Share Based Comp	35,286,101
Tax By Revenue	3.1x
Tax Rate	25.54%
Tr6m	-17.75%
Z Score	13.08

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/TE1 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.7%

$0.28 annual per share

Payout ratio

+45.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+0.1%

0 consecutive years of growth

Total shareholder yield

+3.0%

Next ex-dividend date: 2026-02-13

Performance

FRA/TE1 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/TE1?

Insider, institutional, and short-interest positioning.

Institutional ownership

+116.8%

Share of float held by funds and institutions

Insider ownership

+1.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/TE1 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

35.2

Neutral momentum band

Price vs 200-day MA

-18.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.05

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/TE1

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/TE1 stock rating?

fra/TE1 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/TE1 analysis?

The full report lives at /stocks/fra/TE1/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/TE1?

The latest report frames fra/TE1 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/TE1 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.